Status:
NO_LONGER_AVAILABLE
A Compassionate Access Protocol For Those Patients Who Have Completed A4001029
Lead Sponsor:
ViiV Healthcare
Collaborating Sponsors:
Pfizer
Conditions:
HIV
Eligibility:
All Genders
18+ years
Brief Summary
This is a compassionate study to provide continued access to maraviroc for only those subjects completing study A4001029 who are showing clinical benefit. Assessments of safety and tolerability of mar...
Eligibility Criteria
Inclusion
- Patients having completed study A4001029 in Canada and still deriving clinical benefit.
Exclusion
- None
Key Trial Info
Start Date :
August 1 2009
Trial Type :
EXPANDED_ACCESS
End Date :
July 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00801515
Start Date
August 1 2009
End Date
July 1 2011
Last Update
July 25 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Montreal, Quebec, Canada, H3G 1A4